Wissenschaftliche Veröffentlichungen der Angiologischen Klinik (Auswahl)

  1. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013; 11: 56-70.
  2. Hach-Wunderle V, Bauersachs R, Gerlach HE, Eberle S, Schellong S, Riess H, Carnarius H, Rabe E. Postthrombotic Syndrome Three Years after Deep Venous Thrombosis in the TULIPA PLUS Registry. J Vasc Surg. 2013;57(1):5-12.
  3. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013; 11: 71-80
  4. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Bauersachs R, Breithardt G: Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 2013:
  5. Bauersachs R. Venous thromboembolism: Advances and controversies Clinical presentation of deep vein thrombosis and pulmonary embolism. Best Practice & Research Clinical Haematology. 2012;25:1-9.
  6. Bauersachs RM. [New oral anticoagulants and chronic kidney disease.]. Internist (Berl). 2012 Nov 21;53(12):1431–44.
  7. Bauersachs RM. [Secondary prevention of venous thromboembolism]. Dtsch Med Wochenschr. 2012 Oct;137(40):1994-7.
  8. Bauersachs RM. Use of anticoagulants in elderly patients. Thromb Res. 2012;129(2):107-15.
  9. Bauersachs RM, Gogarten W, Hach-Wunderle V, Harenberg J, Krauspe R, Lindhoff-Last E, Leschke M, Moser M, Mouret P, Im Namen der Rivaroxaban Konsensus Gruppe, et al. Perioperatives Management der Antikoagulation mit Rivaroxaban. Klinikarzt. 2012;41(9):418–25.
  10. Omran H, Bauersachs R, Rubenacker S, Goss F, Hammerstingl C. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost. 2012 Jul;108(1):65-73.
  11. Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S, Hach-Wunderle V, Lindhoff-Last E, Riess H, Schellong S, et al. [Dabigatran therapy - Perioperative management and interpretation of coagulation tests]. Hamostaseologie. 2012 Oct 31;32(4):294-305.
  12. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thromb Haemost. 2012 Jun;107(6):1053-65.
  13. Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Melzer N, Bramlage P, Riess H. CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency. Thromb Haemost. 2011 Jun;105(6):981-8.
  14. Bauersachs RM, Kuhlencordt PJ. [Recent advances in the treatment of superficial vein thrombosis and extracranial carotid artery stenosis]. Dtsch Med Wochenschr. 2011 Feb;136(5):168-71.
  15. Bohlmann MK, Baumann K, Bauersachs R. Thromboembolische Erkrankungen in Schwangerschaft und Wochenbett Prävention und Therapie. Gynäkologe. 2011;44:533–7.
  16. Claus D, Huppert P, Bauersachs R, Diegel H, Hedtmann G. Endovascular therapy of carotid artery stenosis: a prospective case study. J Neurointerv Surg. 2011 Mar 1;2(1):59-64.
  17. Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI, ADOPT Trial Investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011 Dec 8;365(23):2167-77.
  18. Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H. Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY. BMC Cancer. 2011;11:316.
  19. Leizorovicz A, Siguret V, Mottier D, Clonier F, Janas M, Stinson J, Townshend G, Maddalena M, Innohep® in Renal Insufficiency Study Steering Committee. Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep(R) in Renal Insufficiency Study (IRIS). Thromb Res. 2011 Jul;128(1):27-34.
  20. Rabe T, Luxembourg B, Ludwig M, Dinger J, Bauersachs R, Rott H, Mueck AO, Albring C. Contraception and Thrombophilia – A statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists BVF e.V.). Reproduktionsmed Endokrinol 2011;8(Special Issue 1):20-62.
  21. Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499-510.
  22. Harenberg J, Bauersachs R, Diehm C, et al. Antikoagulation im Alter. Internist (Berl). 2010;51(11):1446-55.
  23. Decousus H, Prandoni P, Mismetti P, Bauersachs, R et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363(13):1222-32.
  24. Bauersachs RM, Riess H, Hach-Wunderle V, et al. Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thromb Haemost. 2010;103(4):710-7.
  25. Bauersachs RM, Haas S. Thromboembolieprophylaxe in der Inneren Medizin und der hausärztlichen Versorgung. Internist (Berl). 2010;51(3):314, 316-8, 320-2, passim.
  26. Schellong SM, Gerlach H, Hach-Wunderle V, et al. Diagnosis of deep-vein thrombosis: adherence to guidelines and outcomes in real-world health care. Thromb Haemost. 2009;102(6):1234-40.
  27. Bauersachs RM, Gohlke-Barwolf C. [Cumarines in pregnancy - critical appraisal]. Internist (Berl). 2009;50(1):108-9; author reply 109-10.
  28. Bauersachs RM. Treatment of venous thromboembolism during pregnancy. Thromb Res. 2009;123 Suppl 2:S45-50.
  29. Gerdsen F, Luxembourg B, Langer F, Bauersachs R, Lindhoff-Last E. A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin. Blood Coagul Fibrinolysis. 2008;19(6):477-81.
  30. Bauersachs RM. Neue Antikoagulanzien. Hamostaseologie. 2008;28(1-2):21-6.
  31. Kher A, Bauersachs R, Nielsen JD. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Thromb Haemost. 2007;97(4):505-13.
  32. Bauersachs RM, Manolopoulos K, Hoppe I, Arin MJ, Schleussner E. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost. 2007;5(2):438-9. 16.
  33. Bauersachs R, Alban S. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency. Thromb Haemost. 2007;97(3):498-9.
  34. Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin. 2006;22(6):1109-22.
  35. Luxembourg B, Bauersachs R. Malignom und Thrombose: eine wechselseitige klinische Beziehung. Vasa. 2005;34(4):225-34.
  36. Heidrich H, Rogatti W, Altmann E, et al. [DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]. Vasa. 2003;32(4):235-40.
  37. Schellong SM, Gerlach HE, Tebbe U, Haas S, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H, Bauersachs R. Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study. Thromb Res. 2011 Nov;128(5):417-21.
  38. Bauersachs RM. [Stenting of the femoral artery: the angiologist's perspective]. Hamostaseologie. 2003;23(2):71-3.
  39. Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med. 2003;163(22):2788-9.
  40. Landgraf H, Bauersachs R, Bergau L, et al. Air travel thrombosis 2001. Vasa. 2002;31(1):68-70.
  41. Duprez D, Allegra C, Bauersachs R, et al. Vascular centers in Europe. Results of a panel discussion at the 14th Meeting of the European Chapter of the International Union of Angiology (Cologne, Germany, May 25, 2001). Int Angiol. 2002;21(1):96-8.
  42. Lindhoff-Last E, Eichler P, Stein M, Bauersachs, R et al. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery. Thromb Res. 2000;97(6):387-93.
  43. Bauersachs RM, Lindhoff-Last E, Ehrly AM. [Ambulatory treatment of an acute pulmonary artery embolism in fresh thigh vein thrombosis using low-molecular-weight heparin]. Dtsch Med Wochenschr. 1999;124(49):1485-8.
  44. Schopohl B, Leirmann D, Pohlit LJ, Bauersachs, R et al. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. Int J Radiat Oncol Biol Phys. 1996;36(4):835-40 Zusatzinfos, nützliche Links Weitere Informationen Lageplan Anfahrthinweise Ambulanzen Angiologische Ambulanz Tel. 06151 107-4444 Leitung Direktor: Prof. Dr. med. Rupert Bauersachs Tel. 06151 - 107 4401 Forschung & Publikationen Studien und VeröffentlichungenDarmstädter Angiologischer Arbeitskreis Links Website des Gefäßzentrums Flyer Klinik für Gefäßmedizin

Weitere Informationen

Klinik für Gefäßmedizin

Angiologie Grafenstraße 9
64283 Darmstadt

Tel.: 06151 - 107 4401
Fax: 06151 - 107 4429

angiologie@mail.klinikum-darmstadt.de

Direktor

Prof. Dr. med. Rupert Bauersachs

Tel.: 06151 - 107 4401

Ambulanzen

Angiologische Ambulanz
Tel.: 06151 - 107 4444

Forschung & Publikationen

Studien und Veröffentlichungen

Darmstädter Angiologischer Arbeitskreis